Literature DB >> 19002788

Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

M A Izquierdo1, G L Scheffer, A B Schroeijers, M C de Jong, R J Scheper.   

Abstract

In this review we analyze the data supporting the notion that vault-related MDR, as reflected by LRP/MVP overexpression, represents a marker of drug resistance in vitro and in the clinic. Vaults, besides playing a fundamental biological role, may be involved in a novel mechanism of MDR.

Entities:  

Year:  1998        PMID： 19002788      PMCID： PMC3449569          DOI： 10.1023/A:1008004502861

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


  51 in total

1.  Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III.

Authors:  V A Kickhoefer; R P Searles; N L Kedersha; M E Garber; D L Johnson; L H Rome
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

2.  Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines.

Authors:  C M Laurençot; G L Scheffer; R J Scheper; R H Shoemaker
Journal:  Int J Cancer       Date:  1997-09-17       Impact factor: 7.396

3.  P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.

Authors:  M Michieli; D Damiani; A Ermacora; D Raspadori; A Michelutti; S Grimaz; R Fanin; D Russo; F Lauria; P Masolini; M Baccarani
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

4.  Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP.

Authors:  I Sugawara; S Akiyama; R J Scheper; S Itoyama
Journal:  Cancer Lett       Date:  1997-01-15       Impact factor: 8.679

5.  The major vault protein (MVP100) is contained in cholinergic nerve terminals of electric ray electric organ.

Authors:  C Herrmann; W Volknandt; B Wittich; R Kellner; H Zimmermann
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

6.  The drug resistance-related protein LRP is the human major vault protein.

Authors:  G L Scheffer; P L Wijngaard; M J Flens; M A Izquierdo; M L Slovak; H M Pinedo; C J Meijer; H C Clevers; R J Scheper
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

7.  Membrane transport proteins associated with drug resistance expressed in human melanoma.

Authors:  D Schadendorf; A Makki; C Stahr; A van Dyck; R Wanner; G L Scheffer; M J Flens; R Scheper; B M Henz
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

8.  Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex.

Authors:  D C Chugani; L H Rome; N L Kedersha
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

9.  Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry.

Authors:  N L Kedersha; J E Heuser; D C Chugani; L H Rome
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

10.  Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA.

Authors:  N L Kedersha; L H Rome
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539
View more
  7 in total

Review 1.  Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.

Authors:  Ana F Brito; Mónica Mendes; Ana M Abrantes; José G Tralhão; Maria F Botelho
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

2.  Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.

Authors:  Elizabeth H Kerr; Peter J Frederick; Michael E Egger; Cecil R Stockard; Jeffery Sellers; Debbie DellaManna; Denise K Oelschlager; Hope M Amm; Isam-Eldin Eltoum; J Michael Straughn; Donald J Buchsbaum; William E Grizzle; Lacey R McNally
Journal:  Ann Surg Oncol       Date:  2013-03-24       Impact factor: 5.344

3.  Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.

Authors:  Pedro C Lara; Marta Lloret; Bernardino Clavo; Rosa M Apolinario; Luis Alberto Henríquez-Hernández; Elisa Bordón; Fausto Fontes; Agustín Rey
Journal:  Radiat Oncol       Date:  2009-08-06       Impact factor: 3.481

4.  Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.

Authors:  Lu Kong; Qi Hao; Ying Wang; Ping Zhou; Binbin Zou; Yu-xiang Zhang
Journal:  Oncotarget       Date:  2015-09-29

Review 5.  A highly annotated database of genes associated with platinum resistance in cancer.

Authors:  Dongqing Huang; Sara R Savage; Anna P Calinawan; Chenwei Lin; Bing Zhang; Pei Wang; Timothy K Starr; Michael J Birrer; Amanda G Paulovich
Journal:  Oncogene       Date:  2021-10-13       Impact factor: 9.867

6.  3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.

Authors:  Hiroto Fukushima; Tetsuya Abe; Kazuki Sakamoto; Hiroaki Tsujimoto; Shinji Mizuarai; Shinji Oie
Journal:  BMC Cancer       Date:  2014-08-04       Impact factor: 4.430

7.  A comprehensive profile of circulating RNAs in human serum.

Authors:  Sinan Uğur Umu; Hilde Langseth; Cecilie Bucher-Johannessen; Bastian Fromm; Andreas Keller; Eckart Meese; Marianne Lauritzen; Magnus Leithaug; Robert Lyle; Trine B Rounge
Journal:  RNA Biol       Date:  2017-12-08       Impact factor: 4.652
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.